| __timestamp | ImmunityBio, Inc. | argenx SE |
|---|---|---|
| Wednesday, January 1, 2014 | 1595000 | 15411924 |
| Thursday, January 1, 2015 | 11434000 | 22593274 |
| Friday, January 1, 2016 | 26546000 | 33173050 |
| Sunday, January 1, 2017 | 39778000 | 62224159 |
| Monday, January 1, 2018 | 53418000 | 95607434 |
| Tuesday, January 1, 2019 | 111997000 | 221269028 |
| Wednesday, January 1, 2020 | 139507000 | 400745069 |
| Friday, January 1, 2021 | 195958000 | 580520000 |
| Saturday, January 1, 2022 | 248149000 | 663366000 |
| Sunday, January 1, 2023 | 232366000 | 755113687 |
In pursuit of knowledge
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, argenx SE and ImmunityBio, Inc. have demonstrated contrasting strategies in their R&D investments. Since 2014, argenx SE has consistently outpaced ImmunityBio, Inc., with its R&D expenses growing by an impressive 4,800% by 2023. In contrast, ImmunityBio, Inc. has seen a more modest increase of approximately 14,500% over the same period. This strategic focus on R&D has positioned argenx SE as a leader in the biotech sector, with its 2023 R&D spending reaching nearly three times that of ImmunityBio, Inc. As these companies continue to innovate, their R&D investments will likely play a pivotal role in shaping the future of biotechnology.
Research and Development Investment: Amgen Inc. vs ImmunityBio, Inc.
Comparing Innovation Spending: argenx SE and Alpine Immune Sciences, Inc.
argenx SE or Viking Therapeutics, Inc.: Who Invests More in Innovation?
argenx SE or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: argenx SE vs Soleno Therapeutics, Inc.
Research and Development Expenses Breakdown: BeiGene, Ltd. vs ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ascendis Pharma A/S and ImmunityBio, Inc.
Research and Development: Comparing Key Metrics for Jazz Pharmaceuticals plc and ImmunityBio, Inc.
R&D Insights: How Madrigal Pharmaceuticals, Inc. and ImmunityBio, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Verona Pharma plc and ImmunityBio, Inc.
Research and Development Investment: Arrowhead Pharmaceuticals, Inc. vs ImmunityBio, Inc.
ImmunityBio, Inc. or Protagonist Therapeutics, Inc.: Who Invests More in Innovation?